Pharmaco-Imaging in Drug and Biologics Development [electronic resource] : Fundamentals and Applications /
Moyer, Brian R.editor.
Cheruvu, Narayan P.S.editor.
Hu, Tom C.-C.editor.
American Association of Pharmaceutical Scientists,issuing body.
Advances in drugs and biologics to mitigate or cure some of nature’s most complex medical problems have been incredible to behold.  These accomplishments are due to the actions of a wide theatre of participants from biologists, pharmacologists, geneticists, chemists and manufacturers, molecular biologists, toxicologists, clinicians, nurses, program managers, quality assurance personnel, regulatory professionals and — a new group of innovators — the Imaging Scientists.  Imaging has grown from the microscopy sections put on slides with special stains to now in vivo “slices” created with innovative physics, imaging tracers and contrast agents, and incredibly fast and accurate computational systems.  The world of biology has become one of witnessing the actions of drugs and biologics through the window of mechanical and electrical engineering — creating  instruments and reporter molecules that can help us “see” into our bodies and “paint” them with medical information needed to resolve disease. This book will inspire imagination and elicit even more innovations in the development of new and novel drugs and biologics through imaging.
Description based upon print version of record.
Includes bibliographical references and index.
Imaging Platforms and Drug Development:  An Introduction -- Imaging in Drug Development: Animal Models, Handling and Physiological Constraints -- Considerations for Pre-Clinical Laboratory Animal Imaging Center Design, Setup, and Management suitable for Biomedical Investigation for Drug Discovery -- Pharmaco-Imaging in Translational Science and Research -- The Role of Pharmacokinetics and Allometrics in Imaging: Practical Issues and Considerations -- Quantitative Imaging Using Autoradiographic Techniques -- Pre-Clinical Imaging in Oncology: Considerations and Recommendations for the Imaging Scientist -- Use of Radiolabelled Leukocytes for Drug Evaluation in Man -- Application of Bioluminescence Imaging (BLI) to the Study of the Animal Models of Human Infectious Diseases -- Pre-Clinical Imaging in BSL-3 and BSL-4 Environments:  Imaging Pathophysiology of Highly Pathogenic Infectious Diseases -- Magnetic Resonance as a Tool for Pharmaco-Imaging -- Technologies and Principles of Mass Spectral Imaging -- Regulatory Considerations Involved In Imaging.
Advances in drugs and biologics to mitigate or cure some of nature’s most complex medical problems have been incredible to behold.  These accomplishments are due to the actions of a wide theatre of participants from biologists, pharmacologists, geneticists, chemists and manufacturers, molecular biologists, toxicologists, clinicians, nurses, program managers, quality assurance personnel, regulatory professionals and — a new group of innovators — the Imaging Scientists.  Imaging has grown from the microscopy sections put on slides with special stains to now in vivo “slices” created with innovative physics, imaging tracers and contrast agents, and incredibly fast and accurate computational systems.  The world of biology has become one of witnessing the actions of drugs and biologics through the window of mechanical and electrical engineering — creating  instruments and reporter molecules that can help us “see” into our bodies and “paint” them with medical information needed to resolve disease. This book will inspire imagination and elicit even more innovations in the development of new and novel drugs and biologics through imaging.
Medicine.
Pharmaceutical technology.
Biomedicine, general.
Pharmaceutical Sciences/Technology.